These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29531031)

  • 1. Deletion of dopamine D
    Tomasella E; Bechelli L; Ogando MB; Mininni C; Di Guilmi MN; De Fino F; Zanutto S; Elgoyhen AB; Marin-Burgin A; Gelman DM
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3476-3481. PubMed ID: 29531031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective dopamine D2 receptor deletion from Nkx6.2 expressing cells causes impaired cognitive, motivation and anxiety phenotypes in mice.
    Bechelli L; Tomasella E; Cardoso SL; Belmonte M; Gelman DM
    Sci Rep; 2023 Nov; 13(1):19473. PubMed ID: 37945756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
    de Almeida J; Mengod G
    Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex.
    Graham DL; Durai HH; Garden JD; Cohen EL; Echevarria FD; Stanwood GD
    ACS Chem Neurosci; 2015 Feb; 6(2):297-305. PubMed ID: 25393953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer's Disease.
    Spoleti E; La Barbera L; Cauzzi E; De Paolis ML; Saba L; Marino R; Sciamanna G; Di Lazzaro V; Keller F; Nobili A; Krashia P; D'Amelio M
    Mol Psychiatry; 2024 May; 29(5):1265-1280. PubMed ID: 38228889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional dysregulation causes altered modulation of inhibition by haloperidol.
    Brady LJ; Bartley AF; Li Q; McMeekin LJ; Hablitz JJ; Cowell RM; Dobrunz LE
    Neuropharmacology; 2016 Dec; 111():304-313. PubMed ID: 27480797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.
    Chung DW; Fish KN; Lewis DA
    Am J Psychiatry; 2016 Nov; 173(11):1131-1139. PubMed ID: 27444795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered dendritic distribution of dopamine D2 receptors and reduction in mitochondrial number in parvalbumin-containing interneurons in the medial prefrontal cortex of cannabinoid-1 (CB1) receptor knockout mice.
    Fitzgerald ML; Chan J; Mackie K; Lupica CR; Pickel VM
    J Comp Neurol; 2012 Dec; 520(17):4013-31. PubMed ID: 22592925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of prefrontal parvalbumin interneurons ameliorates working memory deficit even under clinically comparable antipsychotic treatment in a mouse model of schizophrenia.
    Arime Y; Saitoh Y; Ishikawa M; Kamiyoshihara C; Uchida Y; Fujii K; Takao K; Akiyama K; Ohkawa N
    Neuropsychopharmacology; 2024 Mar; 49(4):720-730. PubMed ID: 38049583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia.
    Boley AM; Perez SM; Lodge DJ
    Schizophr Res; 2014 Aug; 157(1-3):238-43. PubMed ID: 24888524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia.
    Stansfield KH; Ruby KN; Soares BD; McGlothan JL; Liu X; Guilarte TR
    Transl Psychiatry; 2015 Mar; 5(3):e522. PubMed ID: 25756805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition.
    Gilani AI; Chohan MO; Inan M; Schobel SA; Chaudhury NH; Paskewitz S; Chuhma N; Glickstein S; Merker RJ; Xu Q; Small SA; Anderson SA; Ross ME; Moore H
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7450-5. PubMed ID: 24794528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shank1 regulates excitatory synaptic transmission in mouse hippocampal parvalbumin-expressing inhibitory interneurons.
    Mao W; Watanabe T; Cho S; Frost JL; Truong T; Zhao X; Futai K
    Eur J Neurosci; 2015 Apr; 41(8):1025-35. PubMed ID: 25816842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area.
    Krabbe S; Duda J; Schiemann J; Poetschke C; Schneider G; Kandel ER; Liss B; Roeper J; Simpson EH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1498-506. PubMed ID: 25675529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam.
    Du Y; Grace AA
    Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27432008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids.
    Citver AS; Shields AM; Ciaccia LM; Schulingkamp RJ; Raffa RB
    J Clin Pharm Ther; 2002 Jun; 27(3):161-8. PubMed ID: 12081629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2-Like Receptors Modulate Intrinsic Properties and Synaptic Transmission of Parvalbumin Interneurons in the Mouse Primary Motor Cortex.
    Cousineau J; Lescouzères L; Taupignon A; Delgado-Zabalza L; Valjent E; Baufreton J; Le Bon-Jégo M
    eNeuro; 2020; 7(3):. PubMed ID: 32321772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dopaminergic deficit hypothesis of schizophrenia: the path to discovery.
    Carlsson A; Carlsson ML
    Dialogues Clin Neurosci; 2006; 8(1):137-42. PubMed ID: 16640125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis.
    Iyo M; Tadokoro S; Kanahara N; Hashimoto T; Niitsu T; Watanabe H; Hashimoto K
    J Clin Psychopharmacol; 2013 Jun; 33(3):398-404. PubMed ID: 23609386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.